FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152343213> ?p ?o ?g. }

• W2152343213 endingPage "830" @default.
• W2152343213 startingPage "816" @default.
• W2152343213 abstract "There is a lack of evidence about the efficacy and safety of anticholinergic drugs and about the optimal anticholinergic drug, if any, for the treatment of adult neurogenic detrusor overactivity (NDO).Review the current evidence on the efficacy, safety, and tolerability of anticholinergic drugs in the treatment of adult NDO.A literature search was conducted from 1966 to May 2011. Meta-analysis of all published randomised controlled trials (RCTs) comparing anticholinergic drugs with placebo and comparing different types, doses, and routes of administration of anticholinergic drugs, in adults with NDO, was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis statement. The primary outcome was patient-reported cure/improvement of overactive bladder symptoms. Secondary outcomes were quality of life (QoL) changes, bladder diary events, urodynamic outcomes, adverse events, and costs to health services.A total of 960 patients from 16 RCTs with mean follow-up of 3.8 wk were included. Anticholinergic drugs were associated with statistically significantly better patient-reported cure/improvement (risk ratio: 2.80; 95% confidence interval [CI], 1.64 to 4.77), higher maximum cystometric capacity (weighted mean difference [WMD]: 49.49; 95% CI, 15.38 to 84.20), higher volume at first contraction (WMD: 49.92; 95% CI, 20.06 to 79.78), and lower maximum detrusor pressure (WMD: -38.30; 95% CI, -53.17 to -23.43) when compared with placebo. The dry-mouth rates were statistically significantly higher with anticholinergics, with no difference in withdrawals because of adverse events. There was no statistically significant difference in any of the outcomes between oxybutynin and other anticholinergics or among different doses and preparations of anticholinergic drugs. No study reported QoL changes or costs to health services.Compared with placebo, anticholinergic treatment in patients with NDO is associated with better patient-reported cure/improvement and significant reduction of maximum detrusor pressure; however, there is a higher incidence of adverse events. None of the anticholinergic drugs or different dosages assessed in this review was superior to another." @default.
• W2152343213 created "2016-06-24" @default.
• W2152343213 creator A5016427578 @default.
• W2152343213 creator A5050271677 @default.
• W2152343213 creator A5060140438 @default.
• W2152343213 creator A5072580057 @default.
• W2152343213 date "2012-11-01" @default.
• W2152343213 modified "2023-10-18" @default.
• W2152343213 title "Anticholinergic Drugs for Adult Neurogenic Detrusor Overactivity: A Systematic Review and Meta-analysis" @default.
• W2152343213 cites W1591365506 @default.
• W2152343213 cites W176893690 @default.
• W2152343213 cites W1964460003 @default.
• W2152343213 cites W1967312126 @default.
• W2152343213 cites W1968701973 @default.
• W2152343213 cites W1993486897 @default.
• W2152343213 cites W2005791359 @default.
• W2152343213 cites W2012621697 @default.
• W2152343213 cites W2012932483 @default.
• W2152343213 cites W2023467722 @default.
• W2152343213 cites W2034740672 @default.
• W2152343213 cites W2036285158 @default.
• W2152343213 cites W2042189800 @default.
• W2152343213 cites W2054938611 @default.
• W2152343213 cites W206367589 @default.
• W2152343213 cites W2068710144 @default.
• W2152343213 cites W2102524054 @default.
• W2152343213 cites W2112829884 @default.
• W2152343213 cites W2116455948 @default.
• W2152343213 cites W2131770336 @default.
• W2152343213 cites W2166571150 @default.
• W2152343213 cites W2171354081 @default.
• W2152343213 cites W2314650606 @default.
• W2152343213 cites W2330911951 @default.
• W2152343213 cites W2417658692 @default.
• W2152343213 doi "https://doi.org/10.1016/j.eururo.2012.02.036" @default.
• W2152343213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22397851" @default.
• W2152343213 hasPublicationYear "2012" @default.
• W2152343213 type Work @default.
• W2152343213 sameAs 2152343213 @default.
• W2152343213 citedByCount "118" @default.
• W2152343213 countsByYear W21523432132012 @default.
• W2152343213 countsByYear W21523432132013 @default.
• W2152343213 countsByYear W21523432132014 @default.
• W2152343213 countsByYear W21523432132015 @default.
• W2152343213 countsByYear W21523432132016 @default.
• W2152343213 countsByYear W21523432132017 @default.
• W2152343213 countsByYear W21523432132018 @default.
• W2152343213 countsByYear W21523432132019 @default.
• W2152343213 countsByYear W21523432132020 @default.
• W2152343213 countsByYear W21523432132021 @default.
• W2152343213 countsByYear W21523432132022 @default.
• W2152343213 countsByYear W21523432132023 @default.
• W2152343213 crossrefType "journal-article" @default.
• W2152343213 hasAuthorship W2152343213A5016427578 @default.
• W2152343213 hasAuthorship W2152343213A5050271677 @default.
• W2152343213 hasAuthorship W2152343213A5060140438 @default.
• W2152343213 hasAuthorship W2152343213A5072580057 @default.
• W2152343213 hasConcept C126322002 @default.
• W2152343213 hasConcept C126894567 @default.
• W2152343213 hasConcept C142724271 @default.
• W2152343213 hasConcept C168563851 @default.
• W2152343213 hasConcept C197934379 @default.
• W2152343213 hasConcept C204787440 @default.
• W2152343213 hasConcept C27081682 @default.
• W2152343213 hasConcept C2777844464 @default.
• W2152343213 hasConcept C2778375690 @default.
• W2152343213 hasConcept C2778689640 @default.
• W2152343213 hasConcept C2778941218 @default.
• W2152343213 hasConcept C2910745098 @default.
• W2152343213 hasConcept C42219234 @default.
• W2152343213 hasConcept C44249647 @default.
• W2152343213 hasConcept C71924100 @default.
• W2152343213 hasConcept C95190672 @default.
• W2152343213 hasConceptScore W2152343213C126322002 @default.
• W2152343213 hasConceptScore W2152343213C126894567 @default.
• W2152343213 hasConceptScore W2152343213C142724271 @default.
• W2152343213 hasConceptScore W2152343213C168563851 @default.
• W2152343213 hasConceptScore W2152343213C197934379 @default.
• W2152343213 hasConceptScore W2152343213C204787440 @default.
• W2152343213 hasConceptScore W2152343213C27081682 @default.
• W2152343213 hasConceptScore W2152343213C2777844464 @default.
• W2152343213 hasConceptScore W2152343213C2778375690 @default.
• W2152343213 hasConceptScore W2152343213C2778689640 @default.
• W2152343213 hasConceptScore W2152343213C2778941218 @default.
• W2152343213 hasConceptScore W2152343213C2910745098 @default.
• W2152343213 hasConceptScore W2152343213C42219234 @default.
• W2152343213 hasConceptScore W2152343213C44249647 @default.
• W2152343213 hasConceptScore W2152343213C71924100 @default.
• W2152343213 hasConceptScore W2152343213C95190672 @default.
• W2152343213 hasIssue "5" @default.
• W2152343213 hasLocation W21523432131 @default.
• W2152343213 hasLocation W21523432132 @default.
• W2152343213 hasOpenAccess W2152343213 @default.
• W2152343213 hasPrimaryLocation W21523432131 @default.
• W2152343213 hasRelatedWork W1559663349 @default.
• W2152343213 hasRelatedWork W1987641034 @default.
• W2152343213 hasRelatedWork W1990821320 @default.
• W2152343213 hasRelatedWork W2040078984 @default.

• next